Advanced BioScience Laboratories, Inc. (ABL Inc.)
Rockville, MD
Program data pending ClinicalTrials.gov matching
60.0
Signal Score
○ FDA Inspections
○ Clinical Trials
○ SEC Filings
✓ Press (1)
○ EMA GMP
○ MHRA GMP
Quick Facts: Advanced BioScience Laboratories, Inc. (ABL Inc.)
- Signal Score
- 60.0/100
- Quality Compliance
- Assessment pending
- Headquarters
- Rockville, MD
- Modalities
- AAV, Lentiviral, Adenoviral, HSV-1, Vaccinia/MVA, Oncolytic Virus, Viral Vaccines, Recombinant Proteins, Cell Banking, Fill-Finish
- Active Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CDMO intelligence platform
About Advanced BioScience Laboratories, Inc. (ABL Inc.)
Auto-created by AI matchmaker. Data verification pending.
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Adenoviral, HSV-1, Vaccinia/MVA, Oncolytic Virus, Viral Vaccines, Recombinant Proteins, Cell Banking, Fill-Finish
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
60.0
Private company
Financial assessment: 60.0/100
Source: SEC EDGAR, press monitoring
Profile-based financial assessment
SEC FilingsPrivate company
Private company
Financial assessment: 60.0/100
Capacity
60.0
Broad modality coverage (10 modalities)
Source: SEC EDGAR, press monitoring, company profiles
Profile-based capacity assessment
Recent Press1 articles
Broad modality coverage (10 modalities)
Recent News 1 articles
Lentiviral Vectors Market Share, Size, Trend, Forecast 2030 - Spherical Insights
Frequently Asked Questions About Advanced BioScience Laboratories, Inc. (ABL Inc.)
What is Advanced BioScience Laboratories, Inc. (ABL Inc.)'s CDMO Signal Score?
Advanced BioScience Laboratories, Inc. (ABL Inc.) has a Signal Score of 60/100, based on quality, operations, financial stability, and capacity data.
Evaluating Advanced BioScience Laboratories, Inc. (ABL Inc.) for a manufacturing program?
Use the free AI matchmaker to compare Advanced BioScience Laboratories, Inc. (ABL Inc.) against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Similar CDMOs
3P Biopharmaceuticals (now 3PBIOVIAN)
Pamplona-Noáin, Spain
Biologics (microbial & mammalian), AAV, Adenoviral, Lentiviral, Cell Therapy, Plasmid DNA, Recombinant Proteins, Biosimilars, Fill/Finish (recombinant proteins & viral vectors)
Vigene Biosciences
Rockville, MD
Signal Score: 72.5
AAV, Lentiviral, Adenoviral
Rose BioSolutions
Rockville, MD
Plasmid DNA, AAV, Lentiviral, Adenoviral, CAR-T, Cell Therapy, Gene Editing, Cell Solutions / Starting Materials
Thermo Fisher Scientific
Plainville, MA · Alachua, FL · Cambridge, MA
Signal Score: 83.1
AAV, Lentiviral, Plasmid DNA, Adenoviral
Exothera
Jumet, BE
Signal Score: 78.1
AAV, Adenoviral, Lentiviral